Cancer BiologybioRxiv
A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling
DOI 10.1038/s41388-021-01906-2
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
1 paper
Recent·Most cited